Early doses: mild nausea appetite changes fatigue Mid titration: symptoms may return briefly digestion adjusts again Higher doses: most patients stabilize fewer day-to-day symptoms Slower titration often improves comfort significantly
The Journal of Clinical Psychiatry , 62 (1), 4145
RNK06138 reduces nuclear ERK5 and attenuates ERK5 Paradoxical activation Previous research has shown that ERK5 kinase inhibitors, including AX15836, can promote ERK5 nuclear translocation and activate ERK5 transcriptional activity, thus resulting in the paradoxical activation of kinase-independent functions upon pharmacological inhibition [40]
Regulatory status: FDA-approved for chronic weight management in adults with obesity or overweight with weight-related comorbidities (2021)
ng thi, Glutathione cng lm gim s cng thng, stress ko di v ci thin cht lng gic ng tt hn
10.1016/j.febslet.2007.04.047 FEBS Lett